COMP <GO>
MREO vs ATNM // EV/EBITDA & P/E VALUATION
Mereo BioPharma Group plc (NASDAQ) VS. Actinium Pharmaceuticals Inc. (Delaware) (NYSE) • 15-METRIC TALLY: MREO 2
— ATNM 2
■ METRIC PARITY
LAST: $0.30 (+1.62%) • MKT CAP: $48.2M
valuation
—
LAST: $1.53 (+10.87%) • MKT CAP: $48.1M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MREO VS. ATNM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MREO | ATNM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | 68.00% | -60.00% | +128.00 | MREO | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | ATNM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.9 | 61.0 | -7.11 | ATNM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $48.2M | $48.1M | $67.5K | MREO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MREO REV | ATNM REV | MREO GROSS % | ATNM GROSS % | MREO FCF | ATNM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $500.0K | $90.0K | — | — | -$31.0M | -$24.7M |
| FY 2024 | $0 | $0 | — | — | -$32.8M | -$33.1M |
| FY 2023 | $10.0M | $81.0K | — | — | -$21.1M | -$47.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MREO // BETA —
ATNM // BETA —